SCHEMBL5501997

SCHEMBL5501997

O=C(CBr)N[C@@H]1C(=O)N2C(C(=O)O)=C(/C=C3\CCN(CC4CC4)C3=O)CS[C@H]12.[NaH]

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.48
MAPT P10636 3/20 0.48
POLB P06746 1/20 0.48
PKM P14618 1/20 0.48
HTT P42858 1/20 0.48
DUSP3 P51452 1/20 0.48
PTPN5 P54829 1/20 0.48
PTPN11 Q06124 1/20 0.48
SPOP O43791 6/20 0.40
CACNA1B Q00975 1/20 0.40
APBA1 Q02410 1/20 0.40
MAPK1 P28482 1/20 0.40
PTGS2 P35354 2/20 0.39
NR1I2 O75469 1/20 0.39
ESR1 P03372 1/20 0.39
PGR P06401 1/20 0.39
KDR P35968 1/20 0.39
DRD2 P14416 1/20 0.38
DRD3 P35462 1/20 0.38
ABCC4 O15439 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5502008 0.98 TDP1 (0.48) TDP1MAPTPOLBPKMHTT
SCHEMBL5501999 0.91 TDP1 (0.40) TDP1MAPTPOLBPKMHTT
SCHEMBL5505828 0.86 TDP1 (0.49) TDP1MAPTPOLBPKMHTT
SCHEMBL5507770 0.85 NAPEPLD (0.56) TDP1MAPTPOLBPKMHTT
SCHEMBL5502024 0.85 CA5A (0.50) TDP1MAPTPOLBPKMHTT
SCHEMBL5507779 0.85 NAPEPLD (0.56) TDP1MAPTPOLBPKMHTT
SCHEMBL5502011 0.85 CA5A (0.50) TDP1MAPTPOLBPKMHTT
SCHEMBL5510426 0.84 CA5A (0.45) TDP1MAPTPOLBPKMHTT
SCHEMBL5505833 0.84 TDP1 (0.49) TDP1MAPTPOLBPKMHTT
SCHEMBL5199365 0.84 TDP1 (0.40) TDP1MAPTPOLBPKMHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0841339-B1 Vinylpyrrolidinon cephalosporin derivatives BASILEA PHARMACEUTICA AG (CH) 2007-02-21 EP disclosed
US-6294668-B1 ANTIBACTERIAL ACTIVITY AGAINST BETA-LACTAM SENSITIVE AND RESISTANT GRAM-POSITIVE BACTERIA, SUCH AS STAPHYLOCOCCI, PNEUMOCOCCI, AND ENTEROCOCCI; USED IN THERAPY OF INFECTIOUS DISEASES CAUSED BY THOSE BACTERIA HOFFMAN-LA ROCHE INC. 2001-09-25 US disclosed
EP-0841339-A1 Vinylpyrrolidinon cephalosporin derivatives F. HOFFMANN-LA ROCHE AG (CH) 1998-05-13 EP disclosed